Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: Is it possible?

被引:42
作者
Kajiyama, Hiroaki [1 ]
Shibata, Kiyosumi [1 ]
Mizuno, Mika [1 ]
Hosono, Satoyo [2 ]
Kawai, Michiyasu [3 ]
Nagasaka, Tetsuro [4 ]
Kikkawa, Fumitaka [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan
[3] Toyohashi Municipal Hosp, Dept Obstet & Gynecol, Toyohashi, Aichi, Japan
[4] Nagoya Univ, Sch Hlth Sci, Nagoya, Aichi 4668550, Japan
关键词
clear-cell carcinoma of the ovary; fertility-sparing surgery; stage; survival; recurrence rate; UNIVERSAL GRADING SYSTEM; PROGNOSTIC-SIGNIFICANCE; CANCER; MULTICENTER; WOMEN;
D O I
10.1093/humrep/der342
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Clear-cell carcinoma of the ovary (CCC) is often diagnosed at childbearing age, or sometimes during treatment for infertility. Therefore, most young women with early-stage CCC wish to preserve their reproductive and endocrine functions if possible. METHODS: Clinicopathologic data collected under the central pathological review system were subjected to survival analyses. We analyzed patients with stage I CCC who underwent fertility-sparing surgery (FSS, n = 16) and compared their long-term survival with those receiving radical surgery (n 205), or patients with non-CCC undergoing FSS (n 64). RESULTS: There was no difference in both the overall survival (OS) and disease-free survival (DFS) between patients with CCC who underwent FSS and those who received radical surgery [CCC/FSS (n = 16) versus CCC/radical (n = 205); OS: P = 0.519, DFS: P = 0.265]. Moreover, patients with CCC who underwent FSS did not show a poorer OS and DFS than non-CCC patients who underwent FSS (CCC/FSS versus non-CCC/FSS; OS: P = 0.584, DFS: P = 0.401), or those at the corresponding stage with no CCC. Furthermore, according to the series of patients with CCC in both the current study and four studies in the literature, there was no difference in the recurrence rate between patients with or without CCC who were treated conservatively (CCC/FSS: 13.2% versus non-CCC/FSS: 10.9%, P = 0.614). CONCLUSIONS: Although our study did not have sufficient power to yield a definite conclusion, our data suggests that at least patients with stage IA CCC may be treated with FSS.
引用
收藏
页码:3297 / 3302
页数:6
相关论文
共 24 条
[1]   Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Aebi, S. ;
Castiglione, M. .
ANNALS OF ONCOLOGY, 2008, 19 :14-16
[2]  
American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P201
[3]  
[Anonymous], NCCN CLIN PRACT GUID
[4]   Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers [J].
Chan, John K. ;
Teoh, Deanna ;
Hu, Jessica M. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :370-376
[5]  
CZERNOBILSKY B, 1970, CANCER-AM CANCER SOC, V25, P762, DOI 10.1002/1097-0142(197004)25:4<762::AID-CNCR2820250404>3.0.CO
[6]  
2-3
[7]   Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system [J].
Ishioka, S ;
Sagae, S ;
Terasawa, K ;
Sugimura, M ;
Nishioka, Y ;
Tsukada, K ;
Kudo, R .
GYNECOLOGIC ONCOLOGY, 2003, 89 (03) :447-452
[8]   Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary? [J].
Kajiyama, Hiroaki ;
Shibata, Kiyosumi ;
Suzuki, Shiro ;
Ino, Kazuhiko ;
Yamamoto, Eiko ;
Mizuno, Kimio ;
Sakakibara, Katsumi ;
Matsuzawa, Katsuji ;
Takeda, Akihiro ;
Kinoshita, Yoshito ;
Kawai, Michiyasu ;
Nagasaka, Tetsuro ;
Nawa, Akihiro ;
Kikkawa, Fumitaka .
GYNECOLOGIC ONCOLOGY, 2008, 111 (03) :523-526
[9]   OVARIAN CLEAR CELL ADENOCARCINOMA [J].
KENNEDY, AW ;
BISCOTTI, CV ;
HART, WR ;
WEBSTER, KD .
GYNECOLOGIC ONCOLOGY, 1989, 32 (03) :342-349
[10]   Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: Clinicopathologic evaluation [J].
Komiyama, S ;
Aoki, D ;
Tominaga, E ;
Susumu, N ;
Udagawa, Y ;
Nozawa, S .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :342-346